Homo sapiens

There are 209,355 papers on aging in Homo sapiens: 23,041 trials and 129,545 observational studies in people, 5,489 in animals, 4,754 in cells, 36,219 reviews. The newest story, Nov 17, 2026: “RNA delivery restored muscle weight in aged immobilized mice”.

Organism

209,355 papers study it212,415 findings

TaxonMeSH

11,082 new papers in 30 daysSee all 209,430 papers on Homo sapiens

  • Human trial23,041
  • Humans129,545
  • Animals5,112
  • Model organisms377
  • Cells4,754
  • In silico6,222

Interventions

410

Exercise

upphysical function3downbody weight2downfatigue2upquality of life2+18OR 0.09

15 studies
  1. Exercise decreases FGF23 in humans Following resistance or interval-running exercise.

    “Fibroblast Growth Factor-23 was lower at 24 h”

    Human trialFollowing resistance or interval-running exerciseblood24 hfemales

    Bone biomarker concentrations at baseline and 24 h after resistance and interval running exercise in eumenorrheic females and oral contraceptive users

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

  2. Exercise improves insulin sensitivity-associated plasma protein profile in humans.

    “A subset of these proteins shifted towards a more insulin-sensitive profile following an exercise intervention in men.”

    Human trialplasmamales

    Blood protein model better predicts future diabetes risk

    Nature metabolism

  3. Exercise showed no clear effect on behavioral accuracy in humans (overweight or obesity; food-related Flanker task) (Accuracy p = 0.7978; reaction time p = 0.7221).

    “Behavioral accuracy remained high, with no significant overall intervention effect (χ2(2) = 0.452, p = 0.7978).”

    Human trialoverweight or obesity; food-related Flanker taskacuten = 17

    Acute Exercise and Food-Related Cognitive Processing in Adults with Overweight or Obesity: An ERP Study

    Life (Basel, Switzerland)

  4. Exercise showed no clear effect on food-related ERP responses in humans (overweight or obesity; food-related Flanker task) (Interaction adjusted p: N2 = 0.1635; P3 = 0.5248; LPP = 0.5248).

    “The primary analyses did not identify significant intervention × target category × congruency interactions after Holm correction”

    Human trialoverweight or obesity; food-related Flanker taskacuten = 17

    Acute Exercise and Food-Related Cognitive Processing in Adults with Overweight or Obesity: An ERP Study

    Life (Basel, Switzerland)

  5. Exercise is associated with change in metabolic syndrome prevalence in humans (Aggregated sex- and age-group trends among Specific Health Checkup participants) (r = -0.852).

    “In males, significant negative correlations were found between changes in MetS prevalence and changes in exercise (r = -0.852) and DPA (r = -0.849).”

    HumansAggregated sex- and age-group trends among Specific Health Checkup participants10 years (2014–2023)males

    Relationships of 10-year changes of physical activity with rates of metabolic syndrome based on Specific Health Examination data: Trend analysis by sex and age groups

    Japanese Journal of Physical Fitness and Sports Medicine

  6. Exercise improves quality of life in humans.

    “has been widely demonstrated to improve physical function, metabolic health and quality of life in older adults.”

    Review

    The Role of Exercise Intervention in Healthy Aging: A Review Focusing on Muscle–Adipose Crosstalk and Its Molecular Mechanisms

    Frontiers in physiology

  7. Exercise improves metabolic health in humans.

    “has been widely demonstrated to improve physical function, metabolic health and quality of life in older adults.”

    Review

    The Role of Exercise Intervention in Healthy Aging: A Review Focusing on Muscle–Adipose Crosstalk and Its Molecular Mechanisms

    Frontiers in physiology

  8. Exercise improves physical function in humans.

    “has been widely demonstrated to improve physical function, metabolic health and quality of life in older adults.”

    Review

    The Role of Exercise Intervention in Healthy Aging: A Review Focusing on Muscle–Adipose Crosstalk and Its Molecular Mechanisms

    Frontiers in physiology

  9. Exercise improves balance function in humans (living in residential care facilities) (MD = 5.56, 95% CrI: 2.68, 8.6 at approximately 900 MET-min/week).

    “Overall exercise demonstrated a positive dose–response association with balance improvement, with the greatest benefit observed at approximately 900 MET-min/week”

    Reviewliving in residential care facilitiesapproximately 900 MET-min/week

    Optimal Exercise Types and Doses for Improving Balance Function Among Older Adults Living in Residential Care: A Systematic Review and Dose–Response Network Meta-analysis

    Frontiers in public health

  10. Exercise improves lower-limb maximal strength in humans (SMD 0.78, 95% CI 0.55 to 1.01).

    “lower-limb maximal strength (SMD 0.78, 95% CI 0.55 to 1.01)”

    Reviewexercise added to caloric restriction versus caloric restriction alone in adults with overweight or obesity

    Incremental effects of exercise during caloric restriction on body composition and lower-limb maximal strength in middle-aged and older adults with overweight or obesity: a systematic review and meta-analysis

    Frontiers in public health

All 27

More on Exercise

GLP-1 receptor agonists

downbody weight2up6-Minute Walk Test1downadjudicated heart failure events1downall-cause hospitalization1+21RR 0.62

11 studies
  1. GLP-1 receptor agonists are associated with major cardiovascular events in humans (aOR 0.72, 95% CI 0.71–0.74).

    “GLP-1RA initiation was associated with reduced risk of MCVE, hospitalization, and mortality among adults with AUD and overweight/obesity”

    HumansAdults with alcohol use disorder and overweight or obesity; comparison with no GLP-1RA prescription1 year35.6% femalesn = 163,681

    Glucagon-like peptide-1 receptor agonists in adults with overweight/obesity and alcohol use disorder: A retrospective cohort study

    European journal of internal medicine

  2. GLP-1 receptor agonists are associated with mortality in humans (aOR 0.20, 95% CI 0.19–0.21).

    “GLP-1RA initiation was associated with reduced risk of MCVE, hospitalization, and mortality among adults with AUD and overweight/obesity”

    HumansAdults with alcohol use disorder and overweight or obesity; comparison with no GLP-1RA prescription1 year35.6% femalesn = 163,681

    Glucagon-like peptide-1 receptor agonists in adults with overweight/obesity and alcohol use disorder: A retrospective cohort study

    European journal of internal medicine

  3. GLP-1 receptor agonists are associated with all-cause hospitalization in humans (aOR 0.28, 95% CI 0.28–0.29).

    “Treatment cohort had lower likelihood of all-cause (aOR=0.28, 95%CI: 0.28,0.29) and alcohol-related (aOR=0.20; 95%CI: 0.20,0.21) hospitalizations”

    HumansAdults with alcohol use disorder and overweight or obesity; comparison with no GLP-1RA prescription1 year35.6% femalesn = 163,681

    Glucagon-like peptide-1 receptor agonists in adults with overweight/obesity and alcohol use disorder: A retrospective cohort study

    European journal of internal medicine

  4. GLP-1 receptor agonists are linked with a higher risk of atopic dermatitis in humans (Genetically proxied exposure in individuals of European ancestry) (OR 1.39, 95% CI 1.26–1.54; p < 0.01).

    “Our study suggests that GLP1R agonists may increase the risk of psoriasis and AD.”

    HumansGenetically proxied exposure in individuals of European ancestry

    Genetic Proxied GLP1R Agonist Exposure and Risk of Psoriasis and Atopic Dermatitis: A Drug-Target Mendelian Randomization Study

    Preprints.orgPreprint

  5. GLP-1 receptor agonists are linked with a higher risk of psoriasis in humans (Genetically proxied exposure in individuals of European ancestry) (OR 1.85, 95% CI 1.56–2.20; p < 0.01).

    “MR analysis indicated that genetically predicted GLP1R agonist exposure was a risk factor for both psoriasis”

    HumansGenetically proxied exposure in individuals of European ancestry

    Genetic Proxied GLP1R Agonist Exposure and Risk of Psoriasis and Atopic Dermatitis: A Drug-Target Mendelian Randomization Study

    Preprints.orgPreprint

  6. GLP-1 receptor agonists are associated with medial epicondylitis in humans (HR 1.518, 95% CI 1.078–2.137).

    “GLP‐1RAs users demonstrated higher risks of trigger finger (HR 1.172, 95% CI: 1.053–1.305) and medial epicondylitis (HR 1.518, 95% CI: 1.078–2.137) compared to SGLT2is users.”

    HumansPatients with type 2 diabetes mellitus; compared with SGLT2 inhibitor users after propensity-score matchingn = 15,303

    Risk of Upper Limb Tendinopathy and Tenosynovitis Comparison Between Glucagon Like Peptide‐1 Receptor Agonists and Sodium‐Glucose Cotransporter 2 Inhibitors

    International journal of rheumatic diseases

  7. GLP-1 receptor agonists are associated with trigger finger in humans (HR 1.172, 95% CI 1.053–1.305).

    “GLP‐1RAs users demonstrated higher risks of trigger finger (HR 1.172, 95% CI: 1.053–1.305) and medial epicondylitis (HR 1.518, 95% CI: 1.078–2.137) compared to SGLT2is users.”

    HumansPatients with type 2 diabetes mellitus; compared with SGLT2 inhibitor users after propensity-score matchingn = 15,303

    Risk of Upper Limb Tendinopathy and Tenosynovitis Comparison Between Glucagon Like Peptide‐1 Receptor Agonists and Sodium‐Glucose Cotransporter 2 Inhibitors

    International journal of rheumatic diseases

  8. GLP-1 receptor agonists were not clearly linked with cortisol in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users).

    “mean cortisol levels were similar between cohorts.”

    HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669

    Drug use linked to more surgery for shoulder arthritis

    The archives of bone and joint surgery

  9. GLP-1 receptor agonists are associated with C-reactive protein in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users) (CRP and ESR: both P < 0.001).

    “GLP-1RA users also demonstrated significantly lower mean CRP and ESR levels (both P < 0.001)”

    HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669

    Drug use linked to more surgery for shoulder arthritis

    The archives of bone and joint surgery

  10. GLP-1 receptor agonists are associated with receipt of major joint injections in humans (Primary shoulder osteoarthritis; propensity-score-matched comparison with non-users) (18.93% versus 16.87%; P < 0.001).

    “A greater proportion of patients in the GLP-1RA cohort received major joint injections (18.93% vs. 16.87%; P < 0.001)”

    HumansPrimary shoulder osteoarthritis; propensity-score-matched comparison with non-usersn = 24,669

    Drug use linked to more surgery for shoulder arthritis

    The archives of bone and joint surgery

All 26

More on GLP-1 receptor agonists

Physical activity

no changeadverse events1no changeC-reactive protein1downdiabetes mellitus1upestimated onset of memory decline1+10−58% to −21% lower odds

10 studies
  1. Physical activity is associated with hypertension in humans (Adjusted analysis) (aPR = 2.08; 95% CI: 1.13–3.83).

    “Low physical activity was also associated with a higher prevalence of measured hypertension compared with high physical activity”

    HumansAdjusted analysisLow physical activity compared with high physical activityn = 231

    Hypertension and Associated Factors Among Employees of a Tertiary Academic–Healthcare Institution in Southwestern Uganda

    International journal of hypertension

  2. Physical activity is associated with obesity in humans (HR per SD = 0.85, 95% CI: 0.80–0.89).

    “Greater overall activity (fPC1) was associated with lower obesity risk (HR per SD = 0.85, 95% CI: 0.80–0.89).”

    HumansOverall activityPer SD increase in fPC1Median follow-up of 8.3 yearsn = 58,877

    Diurnal Patterns of Accelerometer‐Measured Physical Activity, Genetic Risk and Incident Obesity: A Cohort Study of 58 877 Participants

    Diabetes, obesity & metabolism

  3. Physical activity was not clearly linked with C-reactive protein in humans (chronic kidney disease; primary continuous models).

    “No statistically significant associations were observed between activity metrics and serum hs-CRP levels in the primary continuous models.”

    Humanschronic kidney disease; primary continuous modelsserum14 daysn = 118

    Association between physical activity and circulating inflammation markers in middle-aged and older adults with chronic kidney disease

    Clinical and experimental nephrology

  4. Physical activity is associated with heart rate variability in humans (firefighters; physical activity measured in metabolic equivalent minutes).

    “metabolic equivalent minutes (METM) was associated with increased HRV.”

    Humansfirefighters; physical activity measured in metabolic equivalent minutesn = 309

    Cardiovascular disease risk factors as key indicator of heart rate variability in firefighters

    Sport Sciences for Health

  5. Physical activity is associated with estimated onset of memory decline in humans (Higher physical activity at wave 4 compared with sedentary activity) (2.64 years later).

    “Higher physical activity at wave 4, compared with sedentary activity, and social engagement were associated with a later estimated onset of memory decline”

    HumansHigher physical activity at wave 4 compared with sedentary activity

    Cognitive Reserve Proxies and Longitudinal Memory Trajectories in Older Adults: Factors Associated with Cognitive Performance and the Timing of Cognitive Decline

    Journal of Ageing and Longevity

  6. Physical activity is associated with mild cognitive impairment in humans (Parkinson's disease) (57.9% lower odds).

    “Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”

    HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259

    Identifying Exploratory Physical Activity Thresholds Associated With Symptom Severity in Older Adults With Parkinson’s Disease

    Adapted physical activity quarterly : APAQ

  7. Physical activity is associated with diabetes mellitus in humans (Parkinson's disease) (40.6% lower odds).

    “Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”

    HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259

    Identifying Exploratory Physical Activity Thresholds Associated With Symptom Severity in Older Adults With Parkinson’s Disease

    Adapted physical activity quarterly : APAQ

  8. Physical activity is associated with hypertension in humans (Parkinson's disease) (21.1% lower odds).

    “Meeting minimum PA threshold was associated with lower odds of hypertension (21.1%), diabetes (40.6%), and mild cognitive impairment (57.9%; p < .01).”

    HumansParkinson's diseasePhysical Activity Scale for the Elderly score ≥150n = 3,259

    Identifying Exploratory Physical Activity Thresholds Associated With Symptom Severity in Older Adults With Parkinson’s Disease

    Adapted physical activity quarterly : APAQ

  9. Physical activity is linked with a lower risk of rheumatoid arthritis in humans (Two-sample Mendelian randomization).

    “higher physical activity and educational attainment as protective.”

    HumansTwo-sample Mendelian randomization

    Sex Differences in the Burden of Rheumatoid Arthritis in China, 1990-2021: Trends, Projections to 2050, and Mendelian Randomization of Modifiable Risk Factors

    International journal of women's health

  10. Physical activity is associated with metabolic syndrome in humans (Adjusted for potential confounding factors).

    “After adjustment for potential confounding factors, the body mass index (BMI), physical activity level, and smoking status were significantly related to the MetS.”

    HumansAdjusted for potential confounding factorsn = 14,906

    Prevalence and Determinant Factors of Metabolic Syndrome in the Azar-Cohort Population

    Journal of cardiovascular and thoracic research

All 14

More on Physical activity

Smoking

upcardiovascular disease1upestimated 10-year coronary heart disease risk1downgray matter volume1uphigh-risk proximal serrated lesions1+9OR 1.4–1.5

10 studies
  1. Smoking is associated with cardiovascular disease in humans (breast cancer survivors) (aHR 1.93, 95% CI 1.29–2.89).

    “Heavy smoking was associated with a high CVD risk in survivors of breast (aHR, 1.93; 95% CI, 1.29–2.89) and colorectal cancers (1.42; 1.26–1.60).”

    Humansbreast cancer survivorsheavy smoking

    Cardiovascular Risk Factors and Incident Cardiovascular Disease Among Cancer Survivors in Korea

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  2. Smoking is associated with senescence-associated gene expression in humans (smokers).

    “Spatial transcriptomic analysis of smoker lungs demonstrates parallel alterations marked by increased expression of senescence-associated genes”

    Humanssmokerslung

    Tobacco smoke makes mouse lung cells stop dividing

    International journal of molecular sciences

  3. Smoking is associated with gray matter volume in humans (current smoking compared with never smoking) (-9.72 cm3; 95% CI -16.53 to -2.19; p=.005).

    “current smoking (vs never smoking) were linked to 9.72 cm3 smaller gray matter volume (95%CI[-16.53,-2.19],p=.005)”

    Humanscurrent smoking compared with never smokingbrain

    Smoking patterns linked to midlife brain differences

    medRxivPreprint

  4. Smoking is associated with white matter hyperintensity volume in humans (relapsing compared with non-smoking) (+0.15 standard deviations; 95% CI 0.00–0.30; p=.045).

    “Relapsing was associated with 0.15 standard deviations more white matter hyperintensity volume (95%CI[0.00,0.30],p=.045)”

    Humansrelapsing compared with non-smokingbrain

    Smoking patterns linked to midlife brain differences

    medRxivPreprint

  5. Smoking is associated with KCO in humans (Healthy current smokers compared with never and former smokers) (Median 94% versus 106% in never smokers (p = 0.0003) and 102% in former smokers (p = 0.02)).

    “DLCO% and KCO% were lower in current versus never smokers.”

    HumansHealthy current smokers compared with never and former smokerslungn = 170

    Early smoking-related lung function changes in biochemically verified current, former, and never smokers

    Scientific reports

  6. Smoking is associated with within-breath expiratory–inspiratory resistance difference at 5 Hz in humans (Healthy current smokers compared with never and former smokers) (Median 0.57 versus 0.23 in never smokers (p = 0.002) and 0.33 in former smokers (p = 0.006)).

    “within-breath expiratory–inspiratory resistance differences were greater in current smokers”

    HumansHealthy current smokers compared with never and former smokerslungn = 170

    Early smoking-related lung function changes in biochemically verified current, former, and never smokers

    Scientific reports

  7. Smoking is associated with estimated 10-year coronary heart disease risk in humans (Jordanian women; risk estimated using the Framingham risk score).

    “Smoking, physical inactivity, and both general and central obesity were significantly associated with an increased estimated risk of CHD.”

    HumansJordanian women; risk estimated using the Framingham risk scorefemalesn = 230

    Central Obesity and Estimated Coronary Heart Disease Risk Among Jordanian Women Aged 30–50 Years: A Framingham Risk Score Analysis

    Journal of nutrition and metabolism

  8. Smoking is associated with high-risk proximal serrated lesions in humans (OR 1.5, CI 1.12–2.09).

    “Upon secondary analyses, high‐risk SLs were found to occur more frequently in women (OR 1.8, CI: 1.12–3.05) and smokers (OR 1.5, CI: 1.12–2.09).”

    Humansproximal colonn = 3,746

    Risk Factors for Advanced Serrated Lesions in the Proximal Colon

    International journal of cancer

  9. Smoking is associated with proximal serrated lesions in humans (OR 1.4, 95% CI 1.13–1.61).

    “Smoking history (odds ratio (OR) 1.4, 95% confidence interval (CI): 1.13–1.61) and daily aspirin use (OR 0.5, 95% CI: 0.33–0.68) were also associated with the risk of proximal SLs.”

    Humansproximal colonn = 3,746

    Risk Factors for Advanced Serrated Lesions in the Proximal Colon

    International journal of cancer

  10. Smoking is linked with a higher risk of rheumatoid arthritis in humans (Two-sample Mendelian randomization).

    “MR identified elevated body mass index (BMI) and smoking as risk-increasing exposures”

    HumansTwo-sample Mendelian randomization

    Sex Differences in the Burden of Rheumatoid Arthritis in China, 1990-2021: Trends, Projections to 2050, and Mendelian Randomization of Modifiable Risk Factors

    International journal of women's health

All 13

More on Smoking

SGLT2 inhibitors

downacute kidney injury1downacute myocardial infarction1upatrial fibrillation remission1no changebody weight1+15HR 0.64–0.84

8 studies
  1. SGLT2 inhibitors are associated with maximum anion gap in humans (emergency cardiac surgery with cardiopulmonary bypass) (8.05 ± 2.65 versus 6.08 ± 2.45 mmol/L; p = 0.002).

    “The SGLT2i-group exhibited a higher maximum anion gap compared with the non-SGLT2i-group, although values remained within the normal range”

    Humansemergency cardiac surgery with cardiopulmonary bypasspostoperativen = 81

    Evaluation of postoperative changes in anion gap and acid-base parameters in patients receiving sodium–glucose cotransporter‑2 inhibitors undergoing emergency cardiac surgery with cardiopulmonary bypass

    Frontiers in cardiovascular medicine

  2. SGLT2 inhibitors are associated with Fibrosis-4 Index in humans (type 2 diabetes; adjusted comparison with other therapies) (Adjusted difference -0.13 (95% CI -0.19 to -0.08)).

    “The fibrosis-4 index was slightly lower in the inhibitor group”

    Humanstype 2 diabetes; adjusted comparison with other therapiesliver6 monthsn = 493

    Association of Sodium-Glucose Cotransporter-2 Inhibitor Use with Laboratory- and Anthropometry-Derived Indices of Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Retrospective Cohort Study

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  3. SGLT2 inhibitors were not clearly linked with hepatic steatosis index in humans (type 2 diabetes; additional adjustment for change in body weight) (Adjusted difference 0.12 (95% CI -0.35 to 0.58)).

    “After adding the change in body weight to the model, the difference in the hepatic steatosis index disappeared”

    Humanstype 2 diabetes; additional adjustment for change in body weightliver6 monthsn = 493

    Association of Sodium-Glucose Cotransporter-2 Inhibitor Use with Laboratory- and Anthropometry-Derived Indices of Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Retrospective Cohort Study

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  4. SGLT2 inhibitors are associated with body weight in humans (type 2 diabetes of at least 5 years’ duration; comparison with other therapies) (2.26 kg greater decrease (95% CI −2.70 to −1.83 kg)).

    “The body weight fell by 2.26 kg more (95% confidence interval: −2.70 to −1.83).”

    Humanstype 2 diabetes of at least 5 years’ duration; comparison with other therapies6 monthsn = 493

    Association of Sodium-Glucose Cotransporter-2 Inhibitor Use with Laboratory- and Anthropometry-Derived Indices of Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Retrospective Cohort Study

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  5. SGLT2 inhibitors are associated with hepatic steatosis index in humans (type 2 diabetes of at least 5 years’ duration; adjusted comparison with other therapies) (Adjusted difference −0.69 (95% CI −1.13 to −0.25)).

    “The hepatic steatosis index fell more in the inhibitor group”

    Humanstype 2 diabetes of at least 5 years’ duration; adjusted comparison with other therapiesliver6 monthsn = 493

    Association of Sodium-Glucose Cotransporter-2 Inhibitor Use with Laboratory- and Anthropometry-Derived Indices of Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Retrospective Cohort Study

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  6. SGLT2 inhibitors are associated with atrial fibrillation remission in humans (Patients with type 2 diabetes mellitus after radiofrequency catheter ablation) (67% vs 23% remission; p=0.005).

    “The use of sodium-glucose cotransporter-2 inhibitors was associated with a higher remission rate (67% vs 23%; p=0.005).”

    HumansPatients with type 2 diabetes mellitus after radiofrequency catheter ablation

    Electrolyte imbalances as predictors of atrial fibrillation recurrence following radiofrequency catheter ablation in patients with type 2 diabetes mellitus

    Terapevticheskii arkhiv

  7. SGLT2 inhibitors are associated with diabetic ketoacidosis in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (0.25% vs 0.46%; RR 0.53, 95% CI 0.29–0.98).

    “Diabetic ketoacidosis (DKA) events were rare in both groups (0.25% vs 0.46%) but occurred less frequently among SGLT2 inhibitor users”

    Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505

    A diabetes drug class linked to fewer deaths after pneumonia

    Sage open chronic disease

  8. SGLT2 inhibitors are associated with acute kidney injury in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (RR 0.89, 95% CI 0.84–0.94).

    “AKI (RR: 0.89, 95% CI: 0.84-0.94, p < 0.0001)”

    Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505

    A diabetes drug class linked to fewer deaths after pneumonia

    Sage open chronic disease

  9. SGLT2 inhibitors are associated with major adverse respiratory events in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (RR 0.87, 95% CI 0.84–0.91).

    “MAREs (RR: 0.87, 95% CI: 0.84-0.91, p < 0.0001)”

    Humanstype 2 diabetes mellitus following hospitalization for pneumonian = 6,505

    A diabetes drug class linked to fewer deaths after pneumonia

    Sage open chronic disease

  10. SGLT2 inhibitors are associated with mortality in humans (type 2 diabetes mellitus following hospitalization for pneumonia) (8.72% vs 12.27%; RR 0.71, 95% CI 0.64–0.79).

    “SGLT2 inhibitor users had significantly lower 30-day mortality”

    Humanstype 2 diabetes mellitus following hospitalization for pneumonia30 daysn = 6,505

    A diabetes drug class linked to fewer deaths after pneumonia

    Sage open chronic disease

All 19

More on SGLT2 inhibitors

Semaglutide

downmajor adverse cardiovascular events2upbinge eating remission1no changebinge frequency1updiabetic retinopathy complications1+5−19% relative riskHR 0.44–0.73

6 studies
  1. Semaglutide increases binge eating remission in humans.

    “Semaglutide also increased remission in those with binge eating.”

    Human trialParticipants reporting baseline binge episodes; semaglutide versus placebo, both with lifestyle intervention2.4 mg60 weeksn = 31

    Disordered Eating Attitudes and Behaviors in Individuals With <scp>BMI</scp> > 27 kg/m ² Treated by Semaglutide: A 60‐Week Randomized Placebo‐Controlled Trial

    The International journal of eating disorders

  2. Semaglutide showed no clear effect on binge frequency in humans (Semaglutide versus placebo, both with lifestyle intervention).

    “The groups did not differ significantly in binge frequency reductions.”

    Human trialSemaglutide versus placebo, both with lifestyle intervention2.4 mg60 weeksn = 120

    Disordered Eating Attitudes and Behaviors in Individuals With <scp>BMI</scp> > 27 kg/m ² Treated by Semaglutide: A 60‐Week Randomized Placebo‐Controlled Trial

    The International journal of eating disorders

  3. Semaglutide decreases eating disorder psychopathology in humans (Obesity treatment; semaglutide versus placebo, both with lifestyle intervention).

    “Semaglutide reduced eating disorder psychopathology and improved body image relative to placebo at 20 to 60 weeks of treatment for obesity management.”

    Human trialObesity treatment; semaglutide versus placebo, both with lifestyle intervention2.4 mg20 to 60 weeksn = 120

    Disordered Eating Attitudes and Behaviors in Individuals With <scp>BMI</scp> > 27 kg/m ² Treated by Semaglutide: A 60‐Week Randomized Placebo‐Controlled Trial

    The International journal of eating disorders

  4. Semaglutide is associated with major adverse cardiovascular events in humans (obesity; compared with bariatric surgery) (HR 0.73, 95% CI 0.58 to 0.91).

    “lower rate of major adverse cardiovascular events in the semaglutide cohort (MACE; death, myocardial infarction or stroke; HR 0.73, 95% CI 0.58 to 0.91)”

    Humansobesity; compared with bariatric surgery

    Reversal of Heart Age in Adults with Obesity After Initiation of Semaglutide Detected by Serial Electrocardiography

    Preprints.orgPreprint

  5. Semaglutide is associated with mortality in humans (obesity; compared with bariatric surgery) (HR 0.44, 95% CI 0.34 to 0.59).

    “5-year mortality in the semaglutide versus bariatric surgery cohort was lower on semaglutide (hazard ratio [HR] 0.44, 95% CI 0.34 to 0.59)”

    Humansobesity; compared with bariatric surgery5 years

    Reversal of Heart Age in Adults with Obesity After Initiation of Semaglutide Detected by Serial Electrocardiography

    Preprints.orgPreprint

  6. Semaglutide is linked with lower relative ECG age in humans (obesity; compared with bariatric surgery) (−1.28 years at 12 months (95% CI −2.48 to −0.09); −1.86 years at 21 months (95% CI −3.19 to −0.53)).

    “semaglutide was superior to bariatric surgery in reducing relative ECG age: a difference of −1.28 years at 12 months”

    Humansobesity; compared with bariatric surgery12 months

    Reversal of Heart Age in Adults with Obesity After Initiation of Semaglutide Detected by Serial Electrocardiography

    Preprints.orgPreprint

  7. Semaglutide is associated with gastrointestinal intolerance in humans (Newly diagnosed type 2 diabetes).

    “began subcutaneous semaglutide 0.25 mg once weekly, then developed persistent nausea and vomiting, dizziness and a 2 kg weight loss”

    HumansNewly diagnosed type 2 diabetes0.25 mg once weeklyfemalesn = 1

    Case Report: Wernicke encephalopathy precipitated by semaglutide-associated gastrointestinal intolerance in a patient with type 2 diabetes

    Frontiers in endocrinology

  8. Semaglutide lowers the risk of major adverse cardiovascular events in humans (Overweight or obesity; RCT SELECT) (19% reduction in relative risk).

    “The systematic review and meta-analysis showed a reduction in the RR of MACE by 19% with parenteral form of semaglutide (RCT SELECT)”

    ReviewOverweight or obesity; RCT SELECTparenteral

    Safety evaluation of medications for the treatment of obesity or excessive body weight: a systematic review and data meta-analysis

    Terapevticheskii arkhiv

  9. Semaglutide raises the risk of diabetic retinopathy complications in humans (SUSTAIN‐6; compared with placebo) (3.0% vs. 1.8%; hazard ratio 1.76, 95% confidence interval 1.11–2.78).

    “In SUSTAIN‐6, semaglutide increased DR complications compared with placebo (3.0% vs. 1.8%; hazard ratio 1.76, 95% confidence interval 1.11–2.78)”

    ReviewSUSTAIN‐6; compared with placebo

    Ocular Safety of GLP‐1 Receptor Agonists: A Comprehensive Review

    Obesity science & practice

  10. Semaglutide is associated with gastrointestinal adverse events in humans (Nausea reported in 12 studies; diarrhea in 11 studies).

    “The review identified systemic AEs of semaglutide, primarily gastrointestinal events like nausea (12 studies) and diarrhea (11 studies).”

    Review

    Systemic and oral adverse effects of semaglutide reported in randomized controlled trials: a scoping review

    BMC oral health

More on Semaglutide

Alcohol

uphypertension2downassociation between ASPA methylation and chronological age1upcancer incidence1updistal radius fracture1+3+8% cancer cases attributable to alcohol consumptionOR 1.98

6 studies
  1. Alcohol is associated with hypertension in humans (Current alcohol consumption; adjusted analysis) (aPR = 1.74; 95% CI: 1.08–2.78).

    “current alcohol consumption was associated with a higher prevalence of measured hypertension”

    HumansCurrent alcohol consumption; adjusted analysisn = 231

    Hypertension and Associated Factors Among Employees of a Tertiary Academic–Healthcare Institution in Southwestern Uganda

    International journal of hypertension

  2. Alcohol is associated with association between ASPA methylation and chronological age in humans.

    “At the locus level, ASPA 's age association was attenuated in alcohol consumers”

    Humansbuccal swab

    Alcohol consumption is associated with increased prediction error in a buccal swab‐based DNA methylation age prediction model

    Journal of forensic sciences

  3. Alcohol is associated with DNA-methylation-predicted age in humans (Extended model incorporating alcohol consumption, retrained on the combined cohort) (B = −6.84).

    “retained alcohol consumption as a significant negative predictor of age ( B = −6.84, p < 0.001)”

    HumansExtended model incorporating alcohol consumption, retrained on the combined cohortbuccal swabn = 152

    Alcohol consumption is associated with increased prediction error in a buccal swab‐based DNA methylation age prediction model

    Journal of forensic sciences

  4. Alcohol is associated with DNA methylation age prediction error in humans (Regular alcohol consumers compared with non-drinkers) (MAE 9.9 versus 7.7 years).

    “When applied to the alcohol‐consuming cohort, prediction error increased significantly (MAE = 9.9 years; p = 0.046)”

    HumansRegular alcohol consumers compared with non-drinkersbuccal swabn = 62

    Alcohol consumption is associated with increased prediction error in a buccal swab‐based DNA methylation age prediction model

    Journal of forensic sciences

  5. Alcohol is associated with distal radius fracture in humans (Compared with less than weekly alcohol consumption) (OR 1.98, 95% CI 1.04–3.78; p = 0.038).

    “moderate alcohol consumption (1–3 times/week) was associated with higher odds of fracture compared with less than weekly consumption”

    HumansCompared with less than weekly alcohol consumption1–3 times/week

    Moderate alcohol consumption is associated with higher risk of distal radius fracture in middle-aged adults: a case-control study

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

  6. Alcohol is associated with cancer incidence in humans (Population-attributable fraction estimates) (8.0% of cancer cases attributable to alcohol consumption).

    “Overall, tobacco smoking and alcohol consumption accounted for 26.8% and 8.0% of cancer cases”

    HumansPopulation-attributable fraction estimates

    Global cancer in 2024 vs. 2022: current estimates, temporal trends, future projections, and associated factors

    Journal of the National Cancer Center

  7. Alcohol is associated with dysglycemia in humans (Adults in rural Kuppam Mandal) (Adjusted odds ratio 3.2).

    “alcohol consumption (AOR = 3.2)”

    HumansAdults in rural Kuppam Mandaln = 450

    Prevalence and Determinants of Diabetes and Pre-diabetes Among Adults in a Rural Region in India: A Community-Based Cross-Sectional Study

    Cureus

  8. Alcohol induces hypertension in humans.

    “withdrawal produce overlapping but distinct phenotypes, including hypertension, atrial fibrillation, ventricular arrhythmias, sudden death, alcohol-associated cardiomyopathy, heart failure, stroke, and vascular disease.”

    ReviewAcute or binge drinking, sustained heavy intake, chronic intake with episodic binges, and withdrawal

    Alcohol and cardiovascular disease: inter-organ crosstalk, microvascular dysfunction, and cardiovascular ageing

    European heart journal

More on Alcohol

Tirzepatide

downbody weight1downC-reactive protein1downepisodes of worsening heart failure1downIL-61+3

6 studies
  1. Tirzepatide is linked with higher relative ECG age in humans (obesity; compared with bariatric surgery) (+3.96 years, 95% CI +0.56 to +7.36; P=0.022).

    “at 15 months, where relative ECG age was higher on tirzepatide than after surgery (+3.96 years, 95% CI +0.56 to +7.36; P=0.022”

    Humansobesity; compared with bariatric surgery15 months

    Reversal of Heart Age in Adults with Obesity After Initiation of Semaglutide Detected by Serial Electrocardiography

    Preprints.orgPreprint

  2. Tirzepatide is associated with body weight in humans (Switching from semaglutide to tirzepatide versus continuing semaglutide) (3.0 kg greater weight reduction (95% CI, 1.2–5.0)).

    “switching to tirzepatide produced greater weight reduction than continuing semaglutide (difference of 3.0 kg, 95% CI, 1.2–5.0)”

    HumansSwitching from semaglutide to tirzepatide versus continuing semaglutide2 years after target trial emulation enrollmentn = 15,154

    Comparative effectiveness of obesity treatments after initial therapy with semaglutide or tirzepatide: a target trial emulation using data from Cleveland Clinic electronic health records

    EClinicalMedicine

  3. Tirzepatide is associated with multisystem complications in humans (normal BMI (22.23 kg/m2); subcutaneous injection).

    “a temporal association between low-dose tirzepatide (less than the standard starting dose of 2.5 mg) and the onset of multisystem complications.”

    Humansnormal BMI (22.23 kg/m2); subcutaneous injection0.5 mg5 daysfemales

    Multisystem adverse drug events of low-dose tirzepatide in a normal - Weight individual: A case report and literature review

    Therapeutic advances in drug safety

  4. Tirzepatide showed no clear effect on serious adverse events in humans (Overweight or obesity; versus placebo).

    “The risks of developing any serious AEs with the use of tirzepatide, semaglutide, orlistat, and sibutramine were not statistically different from those with placebo.”

    ReviewOverweight or obesity; versus placebo

    Safety evaluation of medications for the treatment of obesity or excessive body weight: a systematic review and data meta-analysis

    Terapevticheskii arkhiv

  5. Tirzepatide decreases IL-6 in humans (25–30% reduction).

    “and interleukin-6 by 25–30% at 72 weeks.”

    Review72 weeks

    Tirzepatide and inflammation: a critical reappraisal of the immunometabolic case for incretin-based therapy

    Reviews in endocrine & metabolic disorders

  6. Tirzepatide decreases C-reactive protein in humans (29–55% reduction).

    “lowers high-sensitivity C-reactive protein (hsCRP) by 29–55% across randomised trials in obesity, heart failure with preserved ejection fraction and obstructive sleep apnoea”

    ReviewTrials in obesity, heart failure with preserved ejection fraction, and obstructive sleep apnea

    Tirzepatide and inflammation: a critical reappraisal of the immunometabolic case for incretin-based therapy

    Reviews in endocrine & metabolic disorders

  7. Tirzepatide decreases episodes of worsening heart failure in humans (People with obesity-related heart failure with preserved ejection fraction in SUMMIT).

    “The improvement was mainly related to fewer episodes of worsening heart failure rather than fewer cardiovascular deaths.”

    ReviewPeople with obesity-related heart failure with preserved ejection fraction in SUMMIT

    Cardiovascular promise requires endpoint discipline: interpreting tirzepatide after SURPASS-CVOT

    Therapeutic advances in endocrinology and metabolism

More on Tirzepatide

Moderate-to-vigorous physical activity

upadherence to protein intake guideline target1downgestational diabetes mellitus1downIL-61downpulse rate1+1OR 0.41

5 studies
  1. Moderate-to-vigorous physical activity is associated with pulse rate in humans (UK university students; multivariable adjustment and false-discovery-rate correction) (β = −0.146; q = 0.447; not significant).

    “Higher MVPA showed directionally lower pulse rate (β = −0.146; q = 0.447) and systolic blood pressure (β = −0.118; q = 0.447), without robust evidence of association.”

    HumansUK university students; multivariable adjustment and false-discovery-rate correctionn = 111

    Physical Activity, Sedentary Behaviour and Nutritional Co-Patterning in Relation to Cardiovascular and Body-Composition Phenotypes in Emerging Adulthood: A Cross-Sectional Study

    Nutrients

  2. Moderate-to-vigorous physical activity is associated with adherence to protein intake guideline target in humans (Japanese adults living in Saga Prefecture).

    “moderate-to-vigorous PA and vigorous-intensity PA were positively associated with adherence to the PRT target.”

    HumansJapanese adults living in Saga Prefecturen = 2,545

    Prevalence of Macronutrient Guideline Adherence and Its Association with Physical Activity Among Japanese Adults Living in Saga Prefecture: A Cross-Sectional Study

    Nutrients

  3. Moderate-to-vigorous physical activity is associated with IL-6 in humans (chronic kidney disease; multivariable adjustment) (B = −0.052 per 30 min/day; 95% CI −0.100 to −0.004; approximately 11.3% lower IL-6).

    “Higher MVPA was associated with lower serum IL-6 levels”

    Humanschronic kidney disease; multivariable adjustmentserumper 30 min/day14 daysn = 118

    Association between physical activity and circulating inflammation markers in middle-aged and older adults with chronic kidney disease

    Clinical and experimental nephrology

  4. Moderate-to-vigorous physical activity is associated with gestational diabetes mellitus in humans (Early pregnancy) (Adjusted OR 0.41, 95% CI 0.16–0.93).

    “a total of at least 30 min moderate-to-vigorous physical activity during the previous 7 days (adjusted OR = 0.41, 95% CI: 0.16–0.93)”

    HumansEarly pregnancyAt least 30 min during the previous 7 daysfemales

    Healthy lifestyles are associated with lower risk of gestational diabetes mellitus: a matched case–control study

    BMC public health

  5. Moderate-to-vigorous physical activity is associated with visceral fat category in humans (Exploratory, unadjusted cross-sectional analysis) (rho = −0.255; approximate 95% CI, −0.38 to −0.12).

    “moderate-to-vigorous physical activity lasting more than 30 min showed a small inverse association with the visceral fat category”

    HumansExploratory, unadjusted cross-sectional analysismore than 30 min

    Cardiovascular Risk Factors and Health Behaviours Among Police Officers and Firefighters in Eastern Slovakia

    Healthcare (Basel, Switzerland)

More on Moderate-to-vigorous physical activity

Combined aerobic and resistance training

upbalance function1downbody fat1upcardiorespiratory fitness1downdepressive symptoms1+4+17% increase

4 studies
  1. Combined aerobic and resistance training increases perceived social support in humans (treatment-resistant depression).

    “while perceived social support markedly increased”

    Human trialtreatment-resistant depressionsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1

    Supervised Combined Exercise as an Intervention in Treatment‐Resistant Depression: A Mixed‐Methods Case Report

    Clinical case reports

  2. Combined aerobic and resistance training decreases perceived stress in humans (treatment-resistant depression).

    “Functional disability and perceived stress were substantially reduced”

    Human trialtreatment-resistant depressionsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1

    Supervised Combined Exercise as an Intervention in Treatment‐Resistant Depression: A Mixed‐Methods Case Report

    Clinical case reports

  3. Combined aerobic and resistance training decreases functional disability in humans (treatment-resistant depression).

    “Functional disability and perceived stress were substantially reduced”

    Human trialtreatment-resistant depressionsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1

    Supervised Combined Exercise as an Intervention in Treatment‐Resistant Depression: A Mixed‐Methods Case Report

    Clinical case reports

  4. Combined aerobic and resistance training improves cardiorespiratory fitness in humans (treatment-resistant depression) (16.7% increase).

    “and a 16.7% increase in CRF.”

    Human trialtreatment-resistant depressionsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1

    Supervised Combined Exercise as an Intervention in Treatment‐Resistant Depression: A Mixed‐Methods Case Report

    Clinical case reports

  5. Combined aerobic and resistance training decreases depressive symptoms in humans (treatment-resistant depression; concurrent clomipramine, lamotrigine, and bromazepam) (57% decrease; MADRS 28 to 12).

    “Following the intervention, depressive symptoms decreased by 57% (MADRS = 12)”

    Human trialtreatment-resistant depression; concurrent clomipramine, lamotrigine, and bromazepamsupervised aerobic and resistance trainingtwice weekly12 weeksfemalesn = 1

    Supervised Combined Exercise as an Intervention in Treatment‐Resistant Depression: A Mixed‐Methods Case Report

    Clinical case reports

  6. Combined aerobic and resistance training decreases body fat in humans (general adult samples).

    “combined aerobic and resistance training reduces fat in general adult samples”

    Reviewgeneral adult samples

    Weight Management Strategies and Aeromedical Support for Military Pilots: A Narrative Review of Interventions and Regulatory Practices

    Frontiers in public health

  7. Combined aerobic and resistance training improves balance function in humans (living in residential care facilities) (MD = 4.72, 95% CrI: 3.23, 6.2 at approximately 710 MET-min/week).

    “combined exercise training at approximately 710 MET-min/week (MD = 4.72, 95% CrI: 3.23, 6.2) was the most favorable intervention for improving balance function.”

    Reviewliving in residential care facilitiesapproximately 710 MET-min/week

    Optimal Exercise Types and Doses for Improving Balance Function Among Older Adults Living in Residential Care: A Systematic Review and Dose–Response Network Meta-analysis

    Frontiers in public health

  8. Combined aerobic and resistance training increases maximal oxygen consumption in humans (People living with HIV) (+3.93 mL·kg−1·min−1 (95% CI 3.19 to 4.68)).

    “Concurrent training improved VO2max by +3.93 mL·kg−1·min−1 (95% CI 3.19 to 4.68; I2 = 0%)”

    ReviewPeople living with HIV

    Long-term effects of physical exercise on cardiorespiratory fitness among adults living with human immunodeficiency virus: a systematic review and meta-analysis

    Sao Paulo medical journal = Revista paulista de medicina

More on Combined aerobic and resistance training

Aerobic exercise

downanxiety symptoms1no changecellular-level T-cell mitochondrial oxygen flow1upcirculating T-cell subset counts1downdepressive symptom severity1+5

3 studies
  1. Aerobic exercise showed no clear effect on magnitude of the acute exercise response in humans (colorectal cancer survivors; compared with a stretching control program).

    “Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes, mitochondrial bioenergetics, or the magnitude of the acute response”

    Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  2. Aerobic exercise showed no clear effect on T-cell mitochondrial bioenergetics in humans (colorectal cancer survivors; compared with a stretching control program) (Largest between-group difference in tissue-level oxidative phosphorylation capacity: −1.76 pmol·s−1·mL blood−1 (95% CI −3.62 to 0.11); p = 0.065).

    “Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes, mitochondrial bioenergetics, or the magnitude of the acute response”

    Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  3. Aerobic exercise showed no clear effect on resting T-cell phenotypes in humans (colorectal cancer survivors; compared with a stretching control program).

    “Twelve weeks of aerobic exercise training did not alter resting T-cell phenotypes”

    Human trialcolorectal cancer survivors; compared with a stretching control programmoderate-intensityblood12 weeksn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  4. Aerobic exercise showed no clear effect on cellular-level T-cell mitochondrial oxygen flow in humans (colorectal cancer survivors; baseline assessment).

    “without change at the cellular level (all p ≥ 0.74)”

    Human trialcolorectal cancer survivors; baseline assessmentmoderate-vigorous intensityT-cellsingle boutn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  5. Aerobic exercise increases tissue-level T-cell mitochondrial oxygen flow in humans (colorectal cancer survivors; baseline assessment) (Routine oxygen flow: +1.50 pmol·s−1·mL blood−1 (95% CI 0.96–2.04); LEAK: +0.44; oxidative phosphorylation states: +1.52–4.54 pmol·s−1·mL blood−1).

    “Acute exercise also increased tissue-level oxygen flow across routine”

    Human trialcolorectal cancer survivors; baseline assessmentmoderate-vigorous intensitybloodsingle boutn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  6. Aerobic exercise increases circulating T-cell subset counts in humans (colorectal cancer survivors; baseline assessment).

    “a single bout of submaximal exercise mobilized circulating T-cells”

    Human trialcolorectal cancer survivors; baseline assessmentmoderate-vigorous intensitybloodsingle boutn = 20

    Acute and Chronic Effects of Aerobic Exercise on Circulating T-Cell Phenotypes and Mitochondrial Bioenergetics in Colorectal Cancer Survivors: A Pilot Ancillary Study of a Randomized Trial

    Research SquarePreprint

  7. Aerobic exercise improves lower-body strength in humans.

    “In the Senior Fitness Test, a statistically significant improvement was identified only in lower-body strength (Z= −2.80; p= 0.002).”

    Human trialmoderaten = 31

    Effect of moderate physical activity on depressive symptoms in patients aged 60 to 69 years

    Atención Familiar

  8. Aerobic exercise decreases depressive symptom severity in humans.

    “A statistically significant decrease in the Yesavage Geriatric Depression Scale score was observed (Z= −3.79; p<0.001).”

    Human trialmoderaten = 31

    Effect of moderate physical activity on depressive symptoms in patients aged 60 to 69 years

    Atención Familiar

  9. Aerobic exercise decreases anxiety symptoms in humans (Individuals with overweight or obesity) (SMD −0.504, 95% CrI −0.891 to −0.117).

    “AE (SMD = −0.504, 95% CrI: −0.891 to −0.117) significantly reduced anxiety symptoms.”

    ReviewIndividuals with overweight or obesity

    Comparative effects of exercise modalities on depression and anxiety in individuals with overweight or obesity: A systematic review with pairwise, network, and dose–response meta-analyses

    Journal of affective disorders

More on Aerobic exercise

Resistance training

no changeCKMT2 activity1downdepressive symptoms1upmuscle mass1upmuscle strength1

3 studies
  1. Resistance training showed no clear effect on CKMT2 activity in humans (Paired biopsies).

    “it was unchanged by 6 months of resistance training in 72 donors with paired biopsies.”

    Human trialPaired biopsiesskeletal muscle6 monthsn = 72

    CKMT2 Marks a Mitochondrial and Oxidative-Fiber Program in Sarcopenic Human Skeletal Muscle: An Integrative Four-Cohort Transcriptomic and Single-Nucleus Analysis

    Omics : a journal of integrative biology

  2. Resistance training decreases depressive symptoms in humans (Individuals with overweight or obesity; versus control) (SMD −1.456, 95% CrI −2.187 to −0.725).

    “resistance training (RT; SMD = −1.456, 95% CrI: −2.187 to −0.725), multicomponent exercise (ME; SMD = −0.942, 95% CrI: −1.644 to −0.240), and aerobic exercise”

    ReviewIndividuals with overweight or obesity; versus control

    Comparative effects of exercise modalities on depression and anxiety in individuals with overweight or obesity: A systematic review with pairwise, network, and dose–response meta-analyses

    Journal of affective disorders

  3. Resistance training increases muscle mass in humans (sarcopenia).

    “resistance exercise was the exercise modality with the most consistent evidence for improvements in muscle strength, muscle mass, and physical function”

    Reviewsarcopeniaskeletal muscle

    Exercise Intervention Strategies for the Prevention and Management of Sarcopenia in Older Adults: A Mechanism-Based Evidence Review

    Journal of Coaching Development

  4. Resistance training improves muscle strength in humans (sarcopenia).

    “resistance exercise was the exercise modality with the most consistent evidence for improvements in muscle strength, muscle mass, and physical function”

    Reviewsarcopeniaskeletal muscle

    Exercise Intervention Strategies for the Prevention and Management of Sarcopenia in Older Adults: A Mechanism-Based Evidence Review

    Journal of Coaching Development

More on Resistance training

Caloric restriction

no changecumulative live birth1uperectile function1upfasting-associated ketosis with high-anion-gap metabolic acidosis1uptotal testosterone1

3 studies
  1. Caloric restriction showed no clear effect on cumulative live birth in humans (aRR 0.936; 95% CI 0.676–1.295; P = 0.689).

    “neither intervention was associated with cumulative live birth compared with usual care”

    Human trialWomen with overweight or obesity planning IVF; compared with usual care, adjusted for baseline waist circumferencefemalesn = 273

    Pre-IVF lifestyle intervention and reproductive outcomes in women with overweight or obesity undergoing IVF: a randomized clinical trial

    Reproductive biology and endocrinology : RB&E

  2. Caloric restriction is associated with fasting-associated ketosis with high-anion-gap metabolic acidosis in humans.

    “The patient was considered to have fasting-associated ketosis with high-anion-gap metabolic acidosis, compatible with probable starvation ketoacidosis, in the setting of aggressive caloric restriction”

    HumansDuring phentermine-assisted weight loss; probable starvation ketoacidosis was not confirmedmales

    Asymptomatic fasting-associated ketosis with high-anion-gap metabolic acidosis during phentermine-assisted weight loss: a case report

    BMC endocrine disorders

  3. Caloric restriction increases total testosterone in humans.

    “medium-to-long-term caloric restriction capable of elevating serum total testosterone.”

    Reviewmedium-to-long-termmales

    Systematic evaluation and network meta-analysis of the effects of different dietary patterns on erectile dysfunction and testosterone in men

    Frontiers in urology

  4. Caloric restriction improves erectile function in humans (compared with standard diet) (IIEF-5 MD 1.68, 95% CI 0.54–2.83).

    “followed by simple caloric restriction (MD = 1.68, 95% CI: 0.54–2.83).”

    Reviewcompared with standard dietmales

    Systematic evaluation and network meta-analysis of the effects of different dietary patterns on erectile dysfunction and testosterone in men

    Frontiers in urology

More on Caloric restriction

Hormone replacement therapy

no changebreast cancer risk1no changecoronary risk1downmenopause Rating Scale total score1

3 studies
  1. Hormone replacement therapy decreases menopause Rating Scale total score in humans (Moderate-to-severe menopausal syndrome; compared with integrative care) (Adjusted mean difference −6.4; 95% CI −7.8 to −5.0).

    “HRT produced more rapid symptomatic improvement at 6 months (adjusted mean difference −6.4; 95% confidence interval −7.8 to −5.0; p < 0.001).”

    Human trialModerate-to-severe menopausal syndrome; compared with integrative care6 monthsfemalesn = 500

    Hormone therapy linked to faster menopause symptom relief

    Journal of Health Science and Reports

  2. Hormone replacement therapy showed no clear effect on breast cancer risk in humans after risk-reducing salpingo-oophorectomy in women without breast cancer.

    “HRT after premenopausal risk‐reducing salpingo‐oophorectomy was not associated with increased breast cancer risk in women without breast cancer”

    Reviewafter risk-reducing salpingo-oophorectomy in women without breast cancerfemales

    Fertility preservation and reproductive counseling in women with hereditary gynecological cancer predisposition: A scoping review of BRCA1/2 and Lynch syndrome care pathways

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

  3. Hormone replacement therapy showed no clear effect on coronary risk in humans (postmenopausal women).

    “hormone replacement therapy does not reduce coronary risk”

    Reviewpostmenopausal womenfemales

    FEATURES OF THE TREATMENT OF CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN: A REVIEW OF CURRENT EVIDENCE

    Ekonomika i sotsium

More on Hormone replacement therapy

Yoga

upbalance1upjoint flexibility1downstiffness1upwalking function1

2 studies
  1. Yoga improves balance in humans (compared with a control group continuing daily routines).

    “Joint flexibility increased (p < 0.001) and balance improved (p < 0.001).”

    Human trialcompared with a control group continuing daily routinesCommon Yoga Protocol45–60 min on a daily basis3 monthsn = 40

    Impact of Common Yoga Protocol on Physical Fitness among Older Adults

    Pedagogy Insights

  2. Yoga improves joint flexibility in humans (compared with a control group continuing daily routines).

    “Joint flexibility increased (p < 0.001) and balance improved (p < 0.001).”

    Human trialcompared with a control group continuing daily routinesCommon Yoga Protocol45–60 min on a daily basis3 monthsn = 40

    Impact of Common Yoga Protocol on Physical Fitness among Older Adults

    Pedagogy Insights

  3. Yoga improves walking function in humans (knee osteoarthritis) (Hedges’ g=0.49, 95% CI 0.23–0.75).

    “Yoga may improve stiffness, walking function, and muscle strength in patients with KOA”

    Reviewknee osteoarthritis

    Effects of Yoga on Stiffness, Walking Function, Muscle Strength, and Quality of Life in Patients With Knee Osteoarthritis

    American journal of physical medicine & rehabilitation

  4. Yoga decreases stiffness in humans (knee osteoarthritis) (Hedges’ g=0.66, 95% CI 0.40–0.92).

    “Yoga significantly improved stiffness (Hedges’ g=0.66, 95% confidence interval [CI] 0.40–0.92, P <0.001)”

    Reviewknee osteoarthritisknee

    Effects of Yoga on Stiffness, Walking Function, Muscle Strength, and Quality of Life in Patients With Knee Osteoarthritis

    American journal of physical medicine & rehabilitation

More on Yoga

All 410

Latest

Dec 2025: 6758Jan 2026: 7436Feb 2026: 7177Mar 2026: 7427Apr 2026: 4011May 2026: 3897Jun 2026: 4807Jul 2026: 5123Aug 2026: 5937Sep 2026: 5875Oct 2026: 7927Nov 2026: 465371,028 papers in 12 months
NPJ Aging

RNA delivery restored muscle weight in aged immobilized mice

An experiment in aged, immobilized mice used fat-based particles carrying circular RNA for the exercise-induced protein irisin and restored muscle fiber size.An experiment in aged, immobilized mice used fat-based particles carrying circular RNA for the exercise-induced protein irisin and restored muscle fiber size.

Mouse studyMuscle

See all 209,430 papers on Homo sapiens